Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Genetic Services Laboratory University of Chicago United States | 7 | 15 |
|
TBC1D24 Gene Deafness, autosomal dominant type 65 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
TBC1D24 Gene Deafness, autosomal recessive type 86 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
TBC1D24 Gene Early infantile epileptic encephalopathy type 16 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
TBC1D24 Gene Familial infantile myoclonic epilepsy NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
TBC1D24 Gene DOOR syndrome NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Comprehensive Epilepsy Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 318 |
|
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States | 287 | 218 |
|
Genomic Unity® Hearing Loss Disorders Analysis Variantyx, Inc. United States | 1 | 318 |
|
AudioloGene Hearing Loss Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 200 |
|
TBC1D24 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 6 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene AG - the Rare Disease Company Germany | 442 | 443 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Centogene AG - the Rare Disease Company Germany | 203 | 194 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.